Filtered By:
Condition: Atrial Fibrillation
Drug: Coumadin
Countries: Israel Health
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 47 results found since Jan 2013.
Use of oral anticoagulation therapy in the first 3 months after the diagnosis of atrial fibrillation in Israel: a population ‐based study
ConclusionIn this real world, population ‐based cohort of patients with newly diagnosed AF, we found a lower than expected rate of OAC prescription within 3 months of diagnosis but an encouraging increase in OAC purchasing over time. Use of NOACs has risen exponentially in only a few years, accounting for a greater pool of AF patients be ing prescribed an OAC.This article is protected by copyright. All rights reserved.
Source: Journal of Cardiovascular Electrophysiology - March 25, 2020 Category: Cardiology Authors: Louise Kezerle,
Meytal Avgil Tsadok,
Adi Berliner Senderey,
Moshe Hoshen,
Maya Leventer ‐Roberts,
Orna Reges,
Morton Leibowitz,
Moti Haim Tags: ORIGINAL ARTICLE Source Type: research
Apixaban in Patients with Atrial Fibrillation and Severe Renal Dysfunction: Findings from a National Registry
CONCLUSIONS: Apixaban might be a reasonable alternative to warfarin in patients with severe renal impairment.PMID:34155848
Source: The Israel Medical Association Journal - June 22, 2021 Category: General Medicine Authors: Avishay Elis Robert Klempfner Chen Gurevitz Ela Gilady Ilan Goldenberg Source Type: research
